The European partnership that aims to jointly negotiate pharmaceutical deals has reached its first collective pricing agreement.
The drug which the partnership agreed to fund is called Spinraza, which is used to treat Spinal Muscular Atrophy.
Spinraza is already being funded by the HSE in Ireland.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team